4.7 Article

Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 658, Issue 2-3, Pages 123-131

Publisher

ELSEVIER
DOI: 10.1016/j.ejphar.2011.02.023

Keywords

Bombesin; Adrenomedullary outflow; Brain; 2-Arachidonoylglycerol; Monoacylglycerol lipase; Cannabinoid CB1 receptor

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology [21790627]
  2. Japan Society for the Promotion of Science [20590702]
  3. Smoking Research Foundation in Japan
  4. Kochi University
  5. Kochi Medical School Hospital
  6. Grants-in-Aid for Scientific Research [20590702, 21790627] Funding Source: KAKEN

Ask authors/readers for more resources

We previously reported the involvement of brain diacylglycerol lipase and cyclooxygenase in intracerebroventricularly (i.c.v.) administered bombesin-induced secretion of noradrenaline and adrenaline from the adrenal medulla in rats. Diacylglycerol can be hydrolyzed by diacylglycerol lipase into 2-arachidonoylglycerol, which may be further hydrolyzed by monoacylglycerol lipase into arachidonic acid, a substrate of cyclooxygenase. 2-Arachidonoylglycerol is a major endocannabinoid, which can inhibit synaptic transmission by presynaptic cannabinoid CB, receptors. Released 2-arachidonoylglycerol is rapidly inactivated by uptake into cells and enzymatic hydrolysis. In the present study, we examined the involvement of brain 2-arachidonoylglycerol and its regulatory role in the bombesin-induced central activation of adrenomedullary outflow using anesthetized rats. The elevation of plasma noradrenaline and adrenaline induced by a submaximal dose of bombesin (1 nmol/animal, i.c.v.) was reduced by MAFP (monoacylglycerol lipase inhibitor) (0.28 and 0.7 mu mol/animal, i.c.v.). JZL184 (selective monoacylglycerol lipase inhibitor) (0.7 and 1.4 mu mol/animal, i.c.v.), ACEA (CB, receptor agonist) (0.7 and 1.4 pi-not/animal, i.c.v.) and AM 404 (endocannabinoid uptake-inhibitor) (80 and 250 nmol/animal, i.c.v.), while AM 251 (CBI receptor antagonist) (90 and 180 nmol/animal, i.c.v.) potentiated the response induced by a small dose of bombesin (0.1 nmol/animal, i.c.v.). These results suggest a possibility that 2-arachidonoylglycerol is endogenously generated in the brain during bombesin-induced activation of central adrenomedullary outflow, thereby inhibiting the peptide-induced response by activation of brain CBI receptors in rats. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available